Catalyst Wire Dossier Catalyst Wire Dossier

Brilacidin

· Cellceutix Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Brilacidin, covering 2018-09-26 to 2022-09-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 [Phase 2]

See pricing